DIABETES

Potential new use of DXB’s drug in US$2.5 Billion market

Next Investors Jun 08, 2022

Yesterday our 2021 Biotech Pick of the Year, Dimerix (ASX:DXB), announced an agreement with the Australian Centre for Accelerating Diabetes Innovation to commence a clinical trial on Diabetic Kidney Disease expected Q4 2022.

AHI partners with Jana Care in US$8 million investment

Finfeed Archived May 20, 2021

Advanced Human Imaging (ASX: AHI) has signed a binding terms sheet with US-based on-device blood pathology company Jana Care Inc.

ASX Listed Tech Stock’s Health App Can Help Fight Obesity and COVID-19

Next Investors Apr 20, 2020

MyFiziq's (ASX: MYQ) technology allows for the easy collection and comparison of measurements for clothing, weight management, athletic goals, and the medical field treating illnesses such as diabetes and obesity..

MyFiziq enables users to get a grip on their health

Finfeed Archived Apr 16, 2020

MyFiziq Limited (ASX: MYQ) has entered a Letter of Intent (LOI) with the Serfaty Clinic to commence testing and to adapt the MyFiziq application in readiness to enter the Brazilian market.

Genetic Technologies poised to unveil market moving news

Finfeed Archived May 07, 2019

Genetic Technologies Ltd (ASX:GTG) has established a Memorandum of Understanding with TGen, an Arizona-based biomedical research institute dedicated to conducting ground-breaking research with life changing results.

Eat pray, love — or just eat more and weigh less

Finfeed Archived Dec 10, 2018

Obesity could be a thing of the past if scientific tests on mice can be translated to humans.